Cannabis Strategic Ventures (OTC: NUGS) this morning
announced the expansion of its independent board of directors and executive team
in preparation to uplist to the OTCQB Venture Market Place and expand its
portfolio with additional brands and assets. Expansion of NUGS’ independent
board of directors is among the final key pieces for OTCQB uplisting. New
appointments include the following: SEC attorney Tad Mailander and Jesus
Quintero, current CFO of MassRoots, have been appointed to the company’s
independent board of directors; Chris Young has been assigned as chief strategy
officer; and Arlene Guzman is named as the company’s vice president of
communications and operations. “Each of these professionals bring crucial
expertise to our brand,” Cannabis Strategic Ventures CEO Simon Yu stated in the
news release. “There are many exciting growth opportunities in the works for
2019 and I look forward to working with our immediate team and strategic
industry partners to expand the Cannabis Strategic Ventures portfolio and
strengthen our position in the cannabis industry.”
To view the full press release, visit http://ibn.fm/khmy1
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is a Los Angeles based firm that
incubates, develops and partners with category leaders within the cannabis
sector. The Firm’s NUGS brand experience provides mentorship and a range of
essential services to emerging and existing Cannabis consumer brands. The
company recently completed a name and symbol change from Cascade Energy, Inc.
Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter
Market with the stock symbol NUGS. For more information, visit the company’s
website at www.CannabisStrategic.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
